Defining a textbook surgical outcome for patients undergoing surgical resection of intermediate and high-grade soft tissue sarcomas of the extremities

Journal of Surgical Oncology
Alexander L LazaridesWilliam C Eward

Abstract

Quality measures for the surgical management soft tissue sarcoma of the extremity are limited. The purpose of this study was to define a textbook surgical outcome (TO) for soft tissue sarcoma of the extremities (STS-E) and to examine its associations with hospital volume and overall survival. All patients in the National Cancer Database undergoing resection of primary STS-E between 2004 and 2015 were identified. The primary outcome was a TO, defined as: hospital length of stay (LOS) <75th percentile, survival >90 days from the date of surgery, no readmission within 30 days of discharge, and negative surgical margins (R0 resection). Overall, 7658 patients met criteria for inclusion; a TO was achieved in 4291 (56%) patients. Of patients who did not achieve TOs, 51.9% (n = 1748) had an extended LOS, and 47.3% (n = 1591) did not have negative margins. Older age, more medical comorbidities, and non-white or black race were independently associated with not receiving a TO (P = .034). With respect to tumor and treatment characteristics, larger tumor size, lower extremity location and higher grade were independently associated with not receiving a TO (P < .001). Hospital volume was not associated with a TO. TOs conferred a significant ...Continue Reading

References

Oct 31, 2002·Statistics in Medicine·Jesus OrbeVicente Núñez-Antón
Mar 23, 2004·American Journal of Epidemiology·Guangyong Zou
Jun 11, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Aileen M DavisUNKNOWN NCI Canada Clinical Trial Group Randomized Trial
Aug 19, 2005·The New England Journal of Medicine·Matthew A ClarkJ Meirion Thomas
Jan 10, 2008·Annals of Surgical Oncology·Karl Y BilimoriaClifford Y Ko
Jan 30, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Joyce Dijs-ElsingaPerla J Marang-van de Mheen
Oct 30, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·N E KolfschotenP J Marang-van de Mheen
May 8, 2013·Clinical Orthopaedics and Related Research·Kevin J BozicMervyn Maze
Oct 18, 2013·The Journal of Bone and Joint Surgery. American Volume·Benjamin K PotterAlexander Stojadinovic
Jun 21, 2015·The Journal of Arthroplasty·Cecily C FroemkePaul J Duwelius
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chun Chieh LinDawn L Hershman
Dec 8, 2016·The Journal of Bone and Joint Surgery. American Volume·John M DundonRichard Iorio
Feb 28, 2017·The British Journal of Surgery·L A D BusweilerUNKNOWN Dutch Upper Gastrointestinal Cancer Audit (DUCA) group
Nov 9, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-Y BlayA Le Cesne
Apr 11, 2018·Journal of Surgical Oncology·Tyler AbarcaBenjamin J Miller
May 13, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Margaret von MehrenJillian L Scavone
Sep 27, 2018·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Pablo PriegoEduardo Lobo
Nov 30, 2018·Clinical Orthopaedics and Related Research·Alexander L LazaridesWilliam C Eward
Dec 1, 2018·Annals of Surgery·Katiuscha MerathTimothy M Pawlik
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Feb 19, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Melissa VosUNKNOWN Dutch Sarcoma Study Group (DSSG)
Mar 14, 2019·JAMA Surgery·Kyle H SheetzJustin B Dimick
Apr 7, 2019·Anticancer Research·Mohamed Abdelgadir AdamDan Blazer
May 14, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-Y BlayUNKNOWN NETSARC/REPPS/RESOS and French Sarcoma Group–Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) Networks
Jun 7, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-Y BlayS Bonvalot
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-Y BlayUNKNOWN NETSARC/REPPS/RESOS and French Sarcoma Group–Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) Networks
Nov 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-Y BlayA Le Cesne
Apr 3, 2020·Anticancer Research·Dimitrios MorisDan G Blazer

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.